GlassScriptPhysician profile
Parul B Jayakar
NPI 1881651396
$81,562.49
in general payments reported to CMS, 2019-2025
27 companies · $22K in 2025
The $22K reported for 2025 was more than what 91% of Clinical Genetics (M.D.) providers received nationally (typical 2025 total: $255).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $143 · 2020: $74.62 · 2021: $188 · 2022: $2,131 · 2023: $22K · 2024: $34K · 2025: $22K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $63K · Travel and Lodging: $12K · Food and Beverage: $3,908.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $62,760.50 |
| Travel and Lodging | $12,358.84 |
| Food and Beverage | $3,907.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $77,228.49 | 2019-2025 | |
| Horizon Therapeutics Plc | $1,400.00 | 2022 | |
| Ns Pharma, INC. | $493.23 | 2021-2025 | Viltepso |
| Biomarin Pharmaceutical INC. | $396.20 | 2020-2025 | Voxzogo 1.2mg, Palynziq |
| Sk Life Science, INC. | $288.79 | 2021-2023 | |
| Ultragenyx Pharmaceutical INC. | $260.85 | 2022-2024 | Dojolvi |
| Travere Therapeutics, INC. | $220.98 | 2019-2024 | Cholbam |
| Amicus Therapeutics, INC. | $202.95 | 2024-2025 | Opfolda, Pombiliti, Galafold |
| Acadia Pharmaceuticals INC | $144.75 | 2023-2025 | Daybue |
| Takeda Pharmaceuticals U.S.A., INC. | $117.13 | 2022-2025 | Vpriv |
| Sarepta Therapeutics, INC. | $111.96 | 2023-2025 | |
| Chiesi USA, INC. | $111.63 | 2023-2024 | Lamzede |
| Mirum Pharmaceuticals, INC. | $108.13 | 2024-2025 | Cholbam, Livmarli, Cholbam |
| Intrabio INC | $87.81 | 2025 | Aqneursa |
| Cycle Pharmaceuticals INC | $55.02 | 2024-2025 | Javygtor, Ormalvi |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $54.92 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $45.90 | 2022-2024 | Sohonos |
| Supernus Pharmaceuticals, INC. | $39.49 | 2022-2023 | Qelbree |
| Ucb, INC. | $33.89 | 2023 | |
| Ptc Therapeutics, INC. | $30.58 | 2025 | |
| Springworks Therapeutics, INC. | $28.55 | 2025 | Gomekli |
| Immedica Pharma US, INC. | $24.24 | 2022 | |
| Albireo Pharma, INC. | $23.89 | 2023 | Bylvay |
| Sentynl Therapeutics, INC. | $20.94 | 2025 | Nulibry |
| Biogen, INC. | $19.47 | 2025 | Skyclarys |
| Aprecia Pharmaceuticals, LLC | $12.70 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Parul Jayakar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.